Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer

E-ISSN： 1097-0142|121|9|1422-1430

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.9, 2015-05, pp. : 1422-1430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

ERG protein expression as a biomarker of prostate cancer

By Falzarano Sara Moscovita Magi-Galluzzi Cristina

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 851-865

Future Medicine

Access to resources Recommend Favorite

ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1029-1033

Spandidos Publications

Access to resources Recommend Favorite

Assessment of long‐term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy

CANCER, Vol. 121, Iss. 22, 2015-11 ,pp. : 4071-4079

John Wiley & Sons Inc

Access to resources Recommend Favorite

TFF3 and survivin expressions associate with a lower survival rate in gastric cancer

By Meng Jia-Rong Tang Hui-Zhong Zhou Kai-Zong Shen Wu-Hong Guo He-Yi

Clinical and Experimental Medicine, Vol. 13, Iss. 4, 2013-11 ,pp. : 297-303

Springer Publishing Company

Access to resources Recommend Favorite